Our Stocks to Watch today include SpongeTech Delivery Systems, Inc (OTCBB: SPNG), Redpoint Bio Corporation (OTCBB: RPBC), Torrent Energy Corporation (OTCBB: TREN), Encysive Pharmaceuticals Inc. (NASD: ENCY), Silver Falcon Mining, Inc. (OTC: SFMI)
Visit http://www.otcpicks.com/ to register for our Daily Market Mover’s Digest Newsletter, and Email Stock Watch Alerts.
SPONGETECH DELIVERY SYSTEMS (OTCBB: SPNG)
Detailed Quote: http://www.otcpicks.com/quotes/SPNG.php
Company Profile: http://www.otcpicks.com/spongetech/spongetech.htm
SpongeTech Delivery Systems is a development stage company which designs, produces, markets and distributes cleaning products for vehicular use utilizing patented technology relating to sponges containing hydrophilic (liquid absorbing) foam polyurethane matrices. The Company's sponges are specially configured with an outer contact layer and an inner matrix, which is loaded with specially formulated soaps and wax that are released when the sponge is applied to a surface with minimal pressure. The Company's products are currently designed specifically for vehicular cleaning use. However, the Company is exploring the possibility of using its patented technology for the development of sponges for other uses, including for use with anti-bacterial, bath and kitchen soaps for household uses, as well as for use as a children's bath foam sponge.
SPNG News:
December 14 - Management of SpongeTech Speak to Investors at Luncheon in Florida
SpongeTech Engaging in Awareness Activities to Better Connect with Investors and the Financial Community as a Whole
SpongeTech Delivery Systems, Inc (OTCBB: SPNG) announced that CEO, Michael Metter, as well as Director Steven Moskowitz, attended a ASC Investor Luncheon in Florida. Alan Stone & Company, a financial communications firm arranges one-on-one meetings between management of brokerage firms, money managers and analysts based at leading financial companies.
CFO Steven Moskowitz commented, "Our participation at the luncheon, in addition to Michael Metter's interviews on the Steve Crowley American Scene Talk Radio Show, is helping to gain new and more exposure for the company. Being in front of the investors in the financial communities is important to us especially regarding the rapid expansion our company has seen. With our products hitting more and more shelves in regional markets in the U.S., as well as in several international markets, we saw as result of the recent trade shows in Las Vegas."
REDPOINT BIO CORPORATION (OTCBB: RPBC)
"Up 15.79% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/RPBC.php
Redpoint Bio Corporation, a development stage biotechnology company, engages in the discovery, development, and commercialization of taste enhancers and taste blockers for the food, beverage, and pharmaceutical industries. Its food and beverage program is focused on identifying flavor enhancers that improve the taste of existing ingredients; reduce the need for excess sugar and salt; and contribute to the development of healthier, better-tasting foods, and beverages. The company's pharmaceutical program uses a biochemical approach aimed at suppressing the bitterness of medicines. Redpoint has a research and development, and license agreement with Givaudan Schweiz AG for the development and commercialization of compounds that enhance sweetness or savory sensation, as well as compounds that block or desensitize bitter taste (bitter blocker compounds) for use in the food and beverage industry. The company was founded in 1995 and is headquartered in Ewing, New Jersey.
RPBC News:
December 14 - Redpoint Bio Signs Research & Technology Development Agreement with The Coca-Cola Company
Redpoint Bio and The Coca-Cola Company to Collaborate on the Development of Technology for Use in Non-Alcoholic Beverages
Redpoint Bio Corporation (OTCBB: RPBC), a company developing ingredients to improve the taste of pharmaceutical, food and beverage products, announced that it has signed a research agreement with The Coca-Cola Company (NYSE: KO - News), the world’s largest beverage company, to develop proprietary technology for use in non-alcoholic beverages.
Under terms of the one-year agreement, for a six month period beginning on the effective date of the agreement, Redpoint has granted Coca-Cola an exclusive right to negotiate to extend and expand the collaboration into a broader, multi-year research, development and commercialization program. For more information, see the related 8-K filing by Redpoint Bio with the Securities and Exchange Commission.
“We are extremely pleased to have established this new research and technology development collaboration with industry leader, The Coca-Cola Company – Redpoint Bio’s second food industry collaboration signed in 2007,” said Ray Salemme, Ph.D., Chief Executive Officer of Redpoint Bio. “We believe this agreement is a further endorsement of Redpoint Bio’s unique capabilities for the discovery and development of beverage technology. We look forward to working with The Coca-Cola Company team.”
Grant DuBois, Ph.D., Director, Ingredient & Product Sciences for The Coca-Cola Company, noted, “We believe that Redpoint Bio’s extensive knowledge of taste science, coupled with their full suite of discovery tools, can contribute to the development of new technology for use in existing and future non-alcoholic beverages.”
TORRENT ENERGY CORPORATION (OTCBB: TREN)
"Up 33.87% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/TREN.php
Torrent Energy Corporation, through its subsidiaries, engages in the exploration for coalbed methane in the Coos Bay region of Oregon and the Chehalis Basin region of Washington State. It holds leases to approximately 118,000 acres of coalbed methane lands in the Coos Bay Basin located approximately 200 miles south of the Columbia River and 80 miles north of the California border. The company also holds leases comprising 100,000 acres located in the Chehalis Basin in Lewis, Cowlitz, and Skamania Counties of Washington; and various lease consisting of 23,735 acres in the Chehalis Basin. In addition, Torrent Energy has an option to acquire 15,280 acres of mineral rights interests in Cowlitz and Lewis Counties, Washington. Torrent Energy is based in Portland, Oregon.
TREN News:
December 14 - Torrent Energy Reports Progress on Financing Efforts and Joint Venture Discussions
Torrent Energy Corporation (OTCBB: TREN) (the "Company") announced that it is making progress on its efforts to establish additional sources of capital for the advancement of its Coos Bay coal-bed methane project. Management said the Company also is in detailed discussions with a prospective joint venture partner that has expressed interest in participating on the project.
John Carlson, president and CEO, said, "While the establishment of a new financing package is taking longer than anticipated, we are making meaningful progress and are optimistic that our efforts to finalize a transaction will be successful. We obviously are working to negotiate a transaction that is in the best interest of Torrent and its shareholders. While we cannot provide a definitive timetable for the completion of a funding arrangement, we will announce the results of these efforts as soon as possible."
ENCYSIVE PHARMACEUTICALS (NASD: ENCY)
"Up 11.25% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/ENCY.php
Encysive Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel synthetic small molecule compounds for the treatment of various cardiovascular, vascular, and related inflammatory diseases. It offers Argatroban, a synthetic direct thrombin inhibitor, for the treatment of heparin-induced thrombocytopenia in the United States and Canada; and Thelin (sitaxsentan sodium), an endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension in the European Union and Australia. It also has three additional compounds in clinical development, including TBC3711, second-generation endothelin receptor antagonist; TBC4746, an oral VLA-4 antagonist; and bimosiamose, a selectin antagonist. In addition, the company provides other research and development programs for various cardiovascular and inflammatory diseases. Encysive Pharmaceuticals has collaboration and licensing agreements with Mitsubishi Pharma Corporation; GlaxoSmithKline plc; Schering Corporation; Schering-Plough, Ltd.; and Revotar Biopharmaceuticals, AG. The company was founded in 1989. It was formerly known as Texas Biotechnology Corporation and changed its name to Encysive Pharmaceuticals, Inc. in 2003. Encysive Pharmaceuticals is headquartered in Houston, Texas.
ENCY News:
December 14 - Encysive Pharmaceuticals Provides THELIN Sales Guidance for 2007 and 2008
Company to Report Fourth Quarter and 2007 Financial Results On Wednesday, March 5, 2008
Encysive Pharmaceuticals Inc. (NASD: ENCY) announced guidance for sales of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets for 2007 and 2008. THELIN is the first selective endothelin A receptor antagonist, and the first once-daily oral treatment available for patients with Pulmonary Arterial Hypertension (PAH) in the European Union (EU).
Encysive received EU marketing authorization for THELIN from the European Commission in August 2006. In November, Encysive received reimbursement in Italy, making THELIN available in the five largest EU markets. THELIN was also approved in Canada and Australia in 2007.
Encysive will report its fourth quarter and full-year 2007 financial results on Wednesday, March 5, 2008. At that time, the Company expects to report 2007 sales of THELIN in the range of approximately $10.5 million to $11.5 million. 2008 will mark the first full year that THELIN will be available in the five largest EU markets. Encysive expects to record sales of THELIN for 2008 in the range of approximately $40 million to $50 million.
As previously announced on July 17, 2007, Encysive engaged the investment banking firm of Morgan Stanley to assist in evaluating the Company's assets and strategic alternatives to maximize stockholder value. The Company is in active discussions with several companies regarding strategic alternatives, and the process is ongoing.
The Company does not expect to publicly disclose further information regarding the status of the review of strategic alternatives until a definitive transaction is entered into or the process is completed. There can be no assurances that any particular alternative will be pursued or that any transaction will occur, or on what terms, or as to the timing of any transaction.
THELIN is indicated for improving exercise capacity in PAH patients classified as World Health Organization (WHO) functional class III. Efficacy has been shown in primary pulmonary hypertension(3) and pulmonary hypertension associated with connective tissue disease (CTD).
The European Commission's centralized licensing procedure permits Encysive to market THELIN in all 27 member states of the EU. THELIN has already been launched in the United Kingdom, Germany, Ireland, Spain, France, Italy and the Netherlands and will be launched in additional EU member states as local governmental approval for reimbursement is obtained.
Encysive is scheduled to give a presentation at the JP Morgan 26th Annual Healthcare Conference, on Thursday, January 10, 2008, in San Francisco. Details for the webcast will be made available at a later date.
SILVER FALCON MINING (OTC: SFMI)
"Up 8.43% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/SFMI.php
Silver Falcon Mining, Inc. is a junior resource production company specializing in gold and silver properties. Silver Falcon Mining, Inc., has acquired the rights to develop and operate the mines of GoldCorp Holdings, Co., on War Eagle Mountain, situated on the Owyhee Gold Trend of the Silver City Mining District in southern Idaho. The War Eagle properties of GoldCorp Holdings, Co., have produced approximately $ 270 Million in gold and silver to date, and are situated adjacent to the open-pit mines of Kinross Gold Co., (NYSE: KGC), which have produced approximately $ 1.8 Billion in gold and silver. Initial production on the mountain is scheduled for fiscal year 2008, with an estimated 15-20 year life-of-mines. Annual yield, at full capacity, is estimated to be $ 215 Million at $ 650 Gold.
SFMI News:
December 13 - Silver Falcon Mining, Inc.'s (SFMI) Drilling Hits New Mineralized Vein Structure
Silver Falcon Mining, Inc. (OTC: SFMI) released the results of an independent limited drilling program conducted on select areas of War Eagle Mountain, a gold property on which Silver Falcon Mining, Inc. has developmental and operating rights to 14 deep-shaft mines covering the Mountain's primary epithermal Gold and Silver-producing veins.
The independent drilling program was conducted by Donald Tully, P. engineer. "Five angle holes, totaling 684 meters (2,245 feet) were drilled In the Oro Fino area. Two angle holes, totaling 312 meters (1,025 feet) were drilled in the Keystone & Illinois Central area. Three vertical holes, totaling 209 meters (685 feet) were drilled in the Cow Cornice Basin area," wrote Mr. Tully.
Mr. Tully added, "The two holes that were drilled in the Keystone & Illinois Central and North Empire zones of the Central Vein system on the Mountain, approximately midway between the North and South shafts of the Poorman mine, struck extremely strong new veins. These structures showed mineable width indications of mineralization, with results of 1,000 ppm of Gold, or 660 g/t Gold (23.27 oz Gold/ton). It is concluded that the War Eagle Mountain property is an excellent exploration bet in a favorable geological environment for discovering additional and new deposits of precious metals, in addition to mining of the existing deposits."
Mr. Pierre Quilliam, President of Silver Falcon Mining, Inc., said, "The vein structures on War Eagle Mountain clearly extend to depth, and without any evidence of diminishing ore values. The deepest veins discovered, so far, extend to the 610 meters (2,000 foot) level and show values of 64 g/t Gold (2.5 oz Gold/ton) over 2.7 meter (9-foot) widths. We are extremely pleased with the drilling results to date."
Silver Falcon Mining, Inc. is an exploration and development Company specializing in high-grade Gold and Silver mining properties in North America.
ABOUT OTCPICKS.COM
OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover’s Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Disclaimer:
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.
Release of Liability:
Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks.com has been compensated eight thousand five hundred dollars by the company for SPNG advertising and promotional services. For a complete list of disclosures go to http://www.otcpicks.com/disclosure_details.php. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor’s sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled.
